Insilico Medicine and Bora propose AI drug alliance worth over $2.5 billion

The planned multi-target partnership would combine Insilico’s Pharma.AI platform with Bora’s drug development, manufacturing and commercialization network, pending definitive agreements between the companies.

Summary

verifying reliability

Terms & Concepts

No specialized terms available for this topic.